Medicines Supply Issues
Written by admin on Friday 24th May 2019
Information on shortages of Diamorphine 5mg Injections, Microgynon 30 and Ovranette. Also Epanutin (phenytoin) 30mg/5ml oral suspension likely to be an issue from 10th June for 6-8 weeks.
Please read the following letter below from Karen Denham
Ref: PH620
Dear Colleague,
We would like to inform you about impending supply issues affecting supplies of Ethinylestradiol 30 microgram/Levonorgestrel 150microgram tablets and diamorphine 5mg injection.
Please see attached communications about these impending issues including a Microgynon ‘Dear Health Care Professional’ letter, which should be circulated within your pharmacy teams.
These communications are being distributed to all GP practices and Community Pharmacies in England.
regards
Karen Denham, Business Support Officer, Pharmacy and Optometry, NHS England and NHS Improvement
There was also an update from the RPS
- for further information, please visit the RPS website
Epanutin
The Department of Health and Social Care (DHSC) has advised that Pfizer expect that Epanutin (phenytoin) 30mg/5ml oral suspension will be out of stock from w/c 10th June for 6-8 weeks.
The Canadian brand of Epanutin® ‘Dilantin-30’ is equivalent to Epanutin 30mg/5ml oral suspension and supplies are available on an ‘unlicensed’ basis.
Different formulations of phenytoin (other than Dilantin 30mg/5ml oral suspension) are not interchangeable and if patients are switched to anything other than ‘Dilantin (phenytoin) 30mg/5ml oral suspension’ careful management of switching and monitoring is required.
- for further information, please visit the RPS website